200 related articles for article (PubMed ID: 37673933)
21. Targeted degradation of MERTK and other TAM receptor paralogs by heterobifunctional targeted protein degraders.
Gadiyar V; Patel G; Chen J; Vigil D; Ji N; Campbell V; Sharma K; Shi Y; Weiss MM; Birge RB; Davra V
Front Immunol; 2023; 14():1135373. PubMed ID: 37545504
[TBL] [Abstract][Full Text] [Related]
22. A Functional Role of GAS6/TAM in Nonalcoholic Steatohepatitis Progression Implicates AXL as Therapeutic Target.
Tutusaus A; de Gregorio E; Cucarull B; Cristóbal H; Aresté C; Graupera I; Coll M; Colell A; Gausdal G; Lorens JB; García de Frutos P; Morales A; Marí M
Cell Mol Gastroenterol Hepatol; 2020; 9(3):349-368. PubMed ID: 31689560
[TBL] [Abstract][Full Text] [Related]
23. Recombinant ACE2 Expression Is Required for SARS-CoV-2 To Infect Primary Human Endothelial Cells and Induce Inflammatory and Procoagulative Responses.
Nascimento Conde J; Schutt WR; Gorbunova EE; Mackow ER
mBio; 2020 Dec; 11(6):. PubMed ID: 33310781
[TBL] [Abstract][Full Text] [Related]
24. Recombinant human plasma gelsolin reverses increased permeability of the blood-brain barrier induced by the spike protein of the SARS-CoV-2 virus.
Suprewicz Ł; Tran KA; Piktel E; Fiedoruk K; Janmey PA; Galie PA; Bucki R
J Neuroinflammation; 2022 Nov; 19(1):282. PubMed ID: 36434734
[TBL] [Abstract][Full Text] [Related]
25. Phosphatidylserine Sensing by TAM Receptors Regulates AKT-Dependent Chemoresistance and PD-L1 Expression.
Kasikara C; Kumar S; Kimani S; Tsou WI; Geng K; Davra V; Sriram G; Devoe C; Nguyen KN; Antes A; Krantz A; Rymarczyk G; Wilczynski A; Empig C; Freimark B; Gray M; Schlunegger K; Hutchins J; Kotenko SV; Birge RB
Mol Cancer Res; 2017 Jun; 15(6):753-764. PubMed ID: 28184013
[TBL] [Abstract][Full Text] [Related]
26. Endothelial cell dysfunction, coagulation, and angiogenesis in coronavirus disease 2019 (COVID-19).
Norooznezhad AH; Mansouri K
Microvasc Res; 2021 Sep; 137():104188. PubMed ID: 34022205
[TBL] [Abstract][Full Text] [Related]
27. Role of the GLUT1 Glucose Transporter in Postnatal CNS Angiogenesis and Blood-Brain Barrier Integrity.
Veys K; Fan Z; Ghobrial M; Bouché A; García-Caballero M; Vriens K; Conchinha NV; Seuwen A; Schlegel F; Gorski T; Crabbé M; Gilardoni P; Ardicoglu R; Schaffenrath J; Casteels C; De Smet G; Smolders I; Van Laere K; Abel ED; Fendt SM; Schroeter A; Kalucka J; Cantelmo AR; Wälchli T; Keller A; Carmeliet P; De Bock K
Circ Res; 2020 Jul; 127(4):466-482. PubMed ID: 32404031
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of Mer and Axl receptor tyrosine kinases in astrocytoma cells leads to increased apoptosis and improved chemosensitivity.
Keating AK; Kim GK; Jones AE; Donson AM; Ware K; Mulcahy JM; Salzberg DB; Foreman NK; Liang X; Thorburn A; Graham DK
Mol Cancer Ther; 2010 May; 9(5):1298-307. PubMed ID: 20423999
[TBL] [Abstract][Full Text] [Related]
29. Molecular profiling of TAM tyrosine kinase receptors and ligands in endometrial carcinoma: An in silico-study.
Dilara Fatma Akin ; Özkan D
Taiwan J Obstet Gynecol; 2023 Mar; 62(2):311-324. PubMed ID: 36965901
[TBL] [Abstract][Full Text] [Related]
30. MERTK receptor tyrosine kinase is a therapeutic target in melanoma.
Schlegel J; Sambade MJ; Sather S; Moschos SJ; Tan AC; Winges A; DeRyckere D; Carson CC; Trembath DG; Tentler JJ; Eckhardt SG; Kuan PF; Hamilton RL; Duncan LM; Miller CR; Nikolaishvili-Feinberg N; Midkiff BR; Liu J; Zhang W; Yang C; Wang X; Frye SV; Earp HS; Shields JM; Graham DK
J Clin Invest; 2013 May; 123(5):2257-67. PubMed ID: 23585477
[TBL] [Abstract][Full Text] [Related]
31. TAM receptors in cardiovascular disease.
McShane L; Tabas I; Lemke G; Kurowska-Stolarska M; Maffia P
Cardiovasc Res; 2019 Jul; 115(8):1286-1295. PubMed ID: 30980657
[TBL] [Abstract][Full Text] [Related]
32. Shedding of the Mer tyrosine kinase receptor is mediated by ADAM17 protein through a pathway involving reactive oxygen species, protein kinase Cδ, and p38 mitogen-activated protein kinase (MAPK).
Thorp E; Vaisar T; Subramanian M; Mautner L; Blobel C; Tabas I
J Biol Chem; 2011 Sep; 286(38):33335-44. PubMed ID: 21828049
[TBL] [Abstract][Full Text] [Related]
33. SARS-CoV-2 infects epithelial cells of the blood-cerebrospinal fluid barrier rather than endothelial cells or pericytes of the blood-brain barrier.
Stüdle C; Nishihara H; Wischnewski S; Kulsvehagen L; Perriot S; Ishikawa H; Schroten H; Frank S; Deigendesch N; Du Pasquier R; Schirmer L; Pröbstel AK; Engelhardt B
Fluids Barriers CNS; 2023 Oct; 20(1):76. PubMed ID: 37875964
[TBL] [Abstract][Full Text] [Related]
34. A critical role of the Gas6-Mer axis in endothelial dysfunction contributing to TA-TMA associated with GVHD.
Furukawa M; Wang X; Ohkawara H; Fukatsu M; Alkebsi L; Takahashi H; Harada-Shirado K; Shichishima-Nakamura A; Kimura S; Ogawa K; Ikezoe T
Blood Adv; 2019 Jul; 3(14):2128-2143. PubMed ID: 31300420
[TBL] [Abstract][Full Text] [Related]
35. Tyro3, Axl, and Mertk receptors differentially participate in platelet activation and thrombus formation.
Zhou J; Yang A; Wang Y; Chen F; Zhao Z; Davra V; Suzuki-Inoue K; Ozaki Y; Birge RB; Lu Q; Wu Y
Cell Commun Signal; 2018 Dec; 16(1):98. PubMed ID: 30541554
[TBL] [Abstract][Full Text] [Related]
36. Mer Tyrosine Kinase Regulates Disseminated Prostate Cancer Cellular Dormancy.
Cackowski FC; Eber MR; Rhee J; Decker AM; Yumoto K; Berry JE; Lee E; Shiozawa Y; Jung Y; Aguirre-Ghiso JA; Taichman RS
J Cell Biochem; 2017 Apr; 118(4):891-902. PubMed ID: 27753136
[TBL] [Abstract][Full Text] [Related]
37. Gas6/TAM Axis Involvement in Modulating Inflammation and Fibrosis in COVID-19 Patients.
Rizzi M; Tonello S; D'Onghia D; Sainaghi PP
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674471
[TBL] [Abstract][Full Text] [Related]
38. Axl and MerTK receptor tyrosine kinases maintain human macrophage efferocytic capacity in the presence of viral triggers.
Grabiec AM; Goenka A; Fife ME; Fujimori T; Hussell T
Eur J Immunol; 2018 May; 48(5):855-860. PubMed ID: 29400409
[TBL] [Abstract][Full Text] [Related]
39. MERTK tyrosine kinase receptor together with TIM4 phosphatidylserine receptor mediates distinct signal transduction pathways for efferocytosis and cell proliferation.
Nishi C; Yanagihashi Y; Segawa K; Nagata S
J Biol Chem; 2019 May; 294(18):7221-7230. PubMed ID: 30846565
[TBL] [Abstract][Full Text] [Related]
40. Increased MerTK expression in circulating innate immune cells of patients with septic shock.
Guignant C; Venet F; Planel S; Demaret J; Gouel-Chéron A; Nougier C; Friggeri A; Allaouchiche B; Lepape A; Monneret G
Intensive Care Med; 2013 Sep; 39(9):1556-64. PubMed ID: 23835724
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
